Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12
Clinical trial NCT00194753 · COMPLETED
Trial details
- NCT number
- NCT00194753
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.